Streetbeat News

Stock Prices

KDP

Bernstein has maintained an Outperform rating on Keurig Dr Pepper but lowered its price target from $40 to $37. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:10 pm

DPZ

Domino's Pizza reported better-than-expected Q3 EPS results and issued FY23 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:08 pm

F

MSFT

NOC

NVDA

QCOM

TSLA

The article covers a range of topics including Microsoft's appeal against a $29B US tax claim by the IRS, insider selling of Qualcomm and Northrop Grumman stocks, and Nvidia's bullish outlook with a predicted 50% stock gain. It also mentions Tesla's warning about the potential slashing of Model 3's tax credit and Ford's ongoing UAW strike. In the crypto space, Bitcoin, Ethereum, and Dogecoin are discussed.

Portfolio Pulse from Akanksha Bakshi

October 12, 2023 | 2:06 pm

F

Ford shares are expected to trade lower after 8,700 union members walked out of the company's Kentucky Truck Plant in Louisville.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 2:01 pm

AMZN

Amazon.com (NASDAQ:AMZN) has outperformed the market over the past 15 years, producing an average annual return of 30.12%. If an investor had bought $1000 of AMZN stock 15 years ago, it would be worth $52,292.70 today.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:01 pm

RMD

ResMed (NYSE:RMD) has received a mix of bullish and indifferent analyst ratings in the last quarter, with no bearish ratings. The average price target is $231.3, indicating potential upside from the current price of $141.0. However, this average has decreased by 13.08% from the previous target of $266.12.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm

SHOP

Shopify (NYSE:SHOP) has received various analyst ratings in the last quarter, with 4 bullish, 6 somewhat bullish, and 12 indifferent. The average price target is $66.91, indicating an upside from the current price of $53.66. This average has increased by 9.44% from the previous average price target of $61.14.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm

RVMD

Over the past 3 months, 6 analysts have published their opinion on Revolution Medicines (NASDAQ:RVMD) stock. The majority of these ratings are bullish, with an average 12-month price target of $37.0, which has increased by 7.25% over the past month.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm

ACMR

ACM Research (NASDAQ:ACMR) has received mixed ratings from analysts in the last quarter, with 2 bullish and 3 indifferent ratings. The average price target is $19.44, which is lower than the current price of $20.14, implying a potential downside. The average price target has increased by 39.86% over the past month.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm

BLK

BlackRock (NYSE:BLK) is set to release its quarterly earnings report on October 13, 2023. Analysts estimate an EPS of $8.47. Last quarter, the company beat EPS by $0.82, which was followed by a 0.0% drop in the share price. Shares of BlackRock were trading at $642.67 as of October 11, with a 52-week increase of 16.36%.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 2:00 pm